Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Behcet's disease].

H ten Hoopen-Neumann1, W I van der Meijden, P M van Hagen

  • 1Academisch Ziekenhuis Rotterdam-Dijkzigt.

Nederlands Tijdschrift Voor Geneeskunde
|March 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study.

BMC immunology·2025
Same author

Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway.

Journal of scleroderma and related disorders·2024
Same author

Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations.

Clinical immunology (Orlando, Fla.)·2024
Same author

Long-term data on efficacy and safety of adalimumab in Behçet's disease.

Clinical immunology (Orlando, Fla.)·2023
Same author

Adult orbital xanthogranuloma: long-term follow-up of treated cases.

Eye (London, England)·2022
Same author

2021 European guideline for the management of vulval conditions.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Behçet's disease, a multisystemic inflammatory disorder, can be challenging to diagnose due to its varied symptoms and lack of specific tests. Early immunomodulating treatment can improve patient outcomes for this condition.

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Background:

  • Behçet's disease is a rare, chronic inflammatory condition affecting multiple organ systems.
  • Its etiology remains unknown, presenting diagnostic challenges.
  • The disease is more prevalent in individuals from Mediterranean and Asian regions.

Observation:

  • Three women presented with recurrent oral aphthae, vaginal ulcers, and skin lesions.
  • Initial blood and biopsy examinations showed no specific abnormalities.
  • Symptoms had persisted for several years, leading to diagnostic delays.

Findings:

  • Diagnosis of Behçet's disease was confirmed based on clinical symptomatology.
  • Patients received immunomodulating treatment.
  • Treatment led to significant improvement in the patients' symptoms.

Related Experiment Videos

Implications:

  • Highlights the importance of clinical diagnosis for Behçet's disease, especially in patients with non-specific symptoms.
  • Suggests that early intervention with immunomodulating therapies can effectively manage the disease.
  • Increased incidence due to migration necessitates greater awareness among healthcare providers globally.